Specialist Physiotherapist in Haematology & Cellular Therapies inLondon inLondon PUBLISHED 9 DEC 2023

Band 7: £54,320 to £60,981 a year Per annum inclusive of HCAS  PERMANENT 

For the full Person Specification and more information regarding the main responsibilities of this role, please refer to the attached Job Description.

Come and be a part of the best NHS trust in England to work for, according to our staff*

UCLH top trust to work at in England for the second year running! : University College London Hospitals NHS Foundation Trust

*In the most recent NHS staff survey UCLH had the highest percentage of staff who said they would recommend us as a place to work, out of all general acute or acute/community NHS trusts in England for the second year in a row.

UCLH top trust to work at in England for the second year running! University College London Hospitals NHS Foundation Trust.

Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work.

This vacancy has been advertised in accordance with the new NHS pay rate which will take effect from autumn 2024. Please note if your employment starts before the 24/25 pay scales are implemented you will be paid under the 23/24 pay scales and any backpay will be adjusted accordingly. Further information can be found at www.jobsincare.com/job/jbnsczd7

The Specialist Physiotherapist in Haematology and Cellular Therapies will be embedded within the transplant service at UCLH. The post holder will be responsible for delivery and on-going evaluation of high-quality specialist prehabilitation and rehabilitation provision for patients undergoing stem cell transplantation and/or CAR T-cell therapy. They will undertake objective assessment of patients within clinics and co-ordinate the provision of remotely delivered prehabilitation/rehabilitation input, predominately via online group exercise sessions. They will provide expert level clinical practice within the fields of physiotherapy and cancer rehabilitation, promoting the role of exercise and embedding the principles of supported self-management.The post-holder will work clinically alongside medical and clinical nurse specialist colleagues to deliver prehabilitation and rehabilitation within the stem cell transplant/CAR T-cell pathways. They will work predominately within the outpatient setting, with input into the inpatient setting as required, providing input and liaison between medical, therapies and other teams involved in the management of patients during hospital admission for transplant/CAR T therapy. This post will also have a particular focus on real-world data collection and service evaluation, and would be ideal for an experienced physiotherapist interested in developing skills in research.

o To provide highly specialised assessment and treatment of adult haematology cancer patients undergoing stem cell transplantation or CAR T, in clinic and outpatient settings.o To take a lead role in the delivery and co-ordination of prehabilitation and rehabilitation in the transplantation and CAR T pathways. This requires working autonomously, incorporating evidenced-based practice in the management of patient care.o To form an important part of the multidisciplinary assessment of patients referred for stem cell transplantation and CAR T, including embedding of physiotherapy assessment within clinic and input into MDT meetings.o To be responsible for daily operational activities and planning, evaluation and development of the team in conjunction with the Clinical Specialist Physiotherapist in Myeloma, Clinical Service Leads for Transplant/CAR T and Haematology Management Team.o To be responsible for the safe delivery of remotely supervised prehabilitation/rehabilitation exercise in group and one to one settings, as indicated.o To liaise with community therapy services on patient care and provide specialist support/ training for any additional identified rehabilitation needs for haematology patients.o To share learning and new understanding of the rehabilitation management of patients with haematological disordered undergoing transplantation and cellular therapies.

For the full Person Specification and more information regarding the main responsibilities of this role, please refer to the attached Job Description.

Come and be a part of the best NHS trust in England to work for, according to our staff*

UCLH top trust to work at in England for the second year running! : University College London Hospitals NHS Foundation Trust

*In the most recent NHS staff survey UCLH had the highest percentage of staff who said they would recommend us as a place to work, out of all general acute or acute/community NHS trusts in England for the second year in a row.

UCLH top trust to work at in England for the second year running! University College London Hospitals NHS Foundation Trust.

Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work.

This vacancy has been advertised in accordance with the new NHS pay rate which will take effect from autumn 2024. Please note if your employment starts before the 24/25 pay scales are implemented you will be paid under the 23/24 pay scales and any backpay will be adjusted accordingly. Further information can be found at www.jobsincare.com/job/jbnsczd7

The Specialist Physiotherapist in Haematology and Cellular Therapies will be embedded within the transplant service at UCLH. The post holder will be responsible for delivery and on-going evaluation of high-quality specialist prehabilitation and rehabilitation provision for patients undergoing stem cell transplantation and/or CAR T-cell therapy. They will undertake objective assessment of patients within clinics and co-ordinate the provision of remotely delivered prehabilitation/rehabilitation input, predominately via online group exercise sessions. They will provide expert level clinical practice within the fields of physiotherapy and cancer rehabilitation, promoting the role of exercise and embedding the principles of supported self-management.The post-holder will work clinically alongside medical and clinical nurse specialist colleagues to deliver prehabilitation and rehabilitation within the stem cell transplant/CAR T-cell pathways. They will work predominately within the outpatient setting, with input into the inpatient setting as required, providing input and liaison between medical, therapies and other teams involved in the management of patients during hospital admission for transplant/CAR T therapy. This post will also have a particular focus on real-world data collection and service evaluation, and would be ideal for an experienced physiotherapist interested in developing skills in research.

o To provide highly specialised assessment and treatment of adult haematology cancer patients undergoing stem cell transplantation or CAR T, in clinic and outpatient settings.o To take a lead role in the delivery and co-ordination of prehabilitation and rehabilitation in the transplantation and CAR T pathways. This requires working autonomously, incorporating evidenced-based practice in the management of patient care.o To form an important part of the multidisciplinary assessment of patients referred for stem cell transplantation and CAR T, including embedding of physiotherapy assessment within clinic and input into MDT meetings.o To be responsible for daily operational activities and planning, evaluation and development of the team in conjunction with the Clinical Specialist Physiotherapist in Myeloma, Clinical Service Leads for Transplant/CAR T and Haematology Management Team.o To be responsible for the safe delivery of remotely supervised prehabilitation/rehabilitation exercise in group and one to one settings, as indicated.o To liaise with community therapy services on patient care and provide specialist support/ training for any additional identified rehabilitation needs for haematology patients.o To share learning and new understanding of the rehabilitation management of patients with haematological disordered undergoing transplantation and cellular therapies.



Locations are approximate. Learn more